Affiliation:
1. Department of Neuroscience, Faculty of Medicine, University of Cádiz, Spain
2. Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Seville, Spain
Abstract
Abstract
Naltrexone, a long-acting, orally effective, opioid antagonist which blocks opioid effects as well as the development of physical dependence, would appear to be a drug ideally suited to addiction treatment. An optimal dosage regimen is critical for the treatment patient compliance in ambulatory opiate detoxification programs. The ideal dosage regimen would be an oral controlled-release system of naltrexone that allowed once-a-day administration providing stable plasma levels.
A naltrexone-Eudragit L complex was produced in aqueous medium from naltrexone hydrochloride solution and Eudragit L30D (30% w/v) previously diluted (6% w/v) and partially neutralized. The antagonistic activity of naltrexone-Eudragit L on morphine-induced thermal antinociception, in comparison with conventional naltrexone, was evaluated, using the mouse hot-plate model. Mice were administered 10 mg kg−1 morphine subcutaneously, 10 min before test, and the antagonist products, either naltrexone-Eudragit L or naltrexone hydrochloride, were administered orally at 0.5, 1, 2, 4, 6, 8, 10, 12, 14 and 16 h before the test.
The results showed that the antagonism induced by naltrexone-Eudragit L was effective until 12 h after drug administration, while that induced by naltrexone hydrochloride disappeared 10 h after its administration. A 23.47% increase of the area under curve was obtained when naltrexone-Eudragit L was administered, compared with that induced by conventional naltrexone. The time taken to decrease the inhibition of analgesic activity to 50% was delayed by 51.80%.
This complexation technique can be considered as a useful tool in the design of oral controlled-release systems capable of inducing a long-lasting effect in-vivo.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference14 articles.
1. Morphine polymeric coprecipitates for controlled release: elaboration and characterization;Alvarez-Fuentes;Drug Dev. Ind. Pharm.,1994
2. Characterization of morphine polymeric coprecipitates. Biopharmaceutical study;Alvarez-Fuentes;Die Pharmazie,1994
3. Preclinical study of a controlled release oral morphine system in rats;Alvarez-Fuentes;Int. J. Pharm.,1996
4. Estudio preliminar para la valoración de un compuesto antagonista opiáceo de liberación controlada;Alvarez-Fuentes;Ind. Farm.,1997
5. Study of a complexation process between naltrexone and Eudragit L as an oral controlled release system;Alvarez-Fuentes;Int. J. Pharm.,1997
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献